Dr. Nadia N. Ramdin
Claim this profileGeisinger Wyoming Valley/Henry Cancer Center
Studies Cancer
Studies Breast Cancer
8 reported clinical trials
18 drugs studied
Area of expertise
1Cancer
HER2 positive
ER positive
ER negative
2Breast Cancer
HER2 positive
ER positive
Stage IV
Affiliated Hospitals
Clinical Trials Nadia N. Ramdin is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
More about Nadia N. Ramdin
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Nadia N. Ramdin has experience with
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Nivolumab
- Trastuzumab
- Pertuzumab
- Paclitaxel
Breakdown of trials Nadia N. Ramdin has run
Cancer
Breast Cancer
Oropharyngeal Carcinoma
Oropharyngeal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nadia N. Ramdin specialize in?
Nadia N. Ramdin focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Nadia N. Ramdin currently recruiting for clinical trials?
Yes, Nadia N. Ramdin is currently recruiting for 5 clinical trials in Wilkes-Barre Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Nadia N. Ramdin has studied deeply?
Yes, Nadia N. Ramdin has studied treatments such as Cisplatin, Intensity-Modulated Radiation Therapy, Nivolumab.
What is the best way to schedule an appointment with Nadia N. Ramdin?
Apply for one of the trials that Nadia N. Ramdin is conducting.
What is the office address of Nadia N. Ramdin?
The office of Nadia N. Ramdin is located at: Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania 18711 United States. This is the address for their practice at the Geisinger Wyoming Valley/Henry Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.